Featured Press Releases

Nature Publication Highlights the Benefits of Tropis® Intradermal

Nature Publication Highlights the Benefits of Tropis® Intradermal

Theravance Biopharma completes enrollment in Phase 3 CYPRESS study of Ampreloxetine for neurogenic orthostatic hypotension

Theravance Biopharma completes enrollment in Phase 3 CYPRESS study of Ampreloxetine for neurogenic orthostatic hypotension

  • 25 Aug 2025

Theravance Biopharma, Inc. announced completion of enrollment in the open-label portion of its...

Rehabtronics Selected by Praxis Spinal Cord Institute to Launch Prelivia Pilot

Rehabtronics Selected by Praxis Spinal Cord Institute to Launch Prelivia Pilot

Biolexis Therapeutics reports positive outcomes for BLX-7006 in an expanded Diet-Induced Obesity (DIO) model study

Biolexis Therapeutics reports positive outcomes for BLX-7006 in an expanded Diet-Induced Obesity (DIO) model study

PCI Pharma Buys Ajinomoto Althea as Part of $1B Plan to Expand Injectable Drug Manufacturing in the U.S

PCI Pharma Buys Ajinomoto Althea as Part of $1B Plan to Expand Injectable Drug Manufacturing in the U.S

Optune Lua® by Novocure Receives CE Mark Approval for Treating Metastatic Non-Small Cell Lung Cancer

Optune Lua® by Novocure Receives CE Mark Approval for Treating Metastatic Non-Small Cell Lung Cancer

BrainStorm Cell Therapeutics appoints Peter J. Pitts to its board.

BrainStorm Cell Therapeutics appoints Peter J. Pitts to its board.

  • rainStorm Cell Therapeutics Inc.
  • 28 May 2026
Nestlé and IdB Holding S.p.A. sign VOWST® licensing deal in Europe

Nestlé and IdB Holding S.p.A. sign VOWST® licensing deal in Europe

  • Nestlé Health Science U.S.
  • 28 May 2026
Ori Biotech and ImmuXell Announce Strategic Partnership and First Patient Dosed

Ori Biotech and ImmuXell Announce Strategic Partnership and First Patient Dosed

  • Ori Biotech
  • 27 May 2026
SK bioscience Signs Technology Transfer Agreement with Colombia’s VECOL to Advance Local Vaccine Manufacturing in Latin America

SK bioscience Signs Technology Transfer Agreement with Colombia’s VECOL to Advance Local Vaccine Manufacturing in Latin America

  • SK bioscience
  • 27 May 2026
Presentations Highlight Results on LEROCHOL® (lerodalcibep-liga) Announced by LIB Therapeutics

Presentations Highlight Results on LEROCHOL® (lerodalcibep-liga) Announced by LIB Therapeutics

  • LIB Therapeutics Inc.
  • 27 May 2026
Lundbeck Receives Marketing Authorization in South Korea for Vyepti® (eptinezumab) for the Preventive Treatment of Migraine

Lundbeck Receives Marketing Authorization in South Korea for Vyepti® (eptinezumab) for the Preventive Treatment of Migraine

  • H. Lundbeck A/S
  • 26 May 2026
The Digital Pharma Advances Conference 2026

Most Popular
May   2026
M T W T F S S
        1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.